Estimates Revisions IP Group Plc OTC Markets
Stocks
IPZYF
GB00B128J450
Investment Management & Fund Operators
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8615 USD | +4.50% |
|
-.--% | +9.05% |
| 06:03am | IP Group investee Istesso starts phase 2 arthritis trial of leramistat | AN |
| 03:06am | Istesso Starts Phase 2 Clinical Trial Of Leramistat In Sarcopenia | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- IPO Stock
- IPZYF Stock
- Consensus IP Group Plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
